Hemophilia - 95 Studies Found Completed : Musculoskeletal Function in Hemophilia : Hemophilia : 2006-05-09 Completed : Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients : Hemophilia A : 2009-06-04 : Biological: Moroctocog alfa ( AF-CC) Completed : Quality of Life in Adult Patients With Severe Haemophilia in Turkey : Haemophilia : 2012-06-17 Recruiting : Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A : Haemophilia A : 2013-03-13 : Biological: Optivate 500IU Completed : Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A : Hemophilia A : 2005-08-30 : Genetic: ReFacto AF Genetic: B-Domain dele Completed : Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment : Hemophilia A : 2008-02-04 : Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222) Completed : Phase I/IIa Study of FIXFc in Hemophilia B Patients : Hemophilia B : 2008-07-14 : Drug: rFIXFc As specified in the treatment arm Other Active, not recruiting : A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A : Hemophilia A : 2012-03-28 : Biological: BAY94-9027 Intravenous infusion of BAY94-9027 Completed : Canadian Hemophilia Prophylaxis Study : Severe Hemophilia A : 2010-03-01 : Biological: Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS) Recruiting : Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." : Hemophilia A : 2015-10-20 : Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222) <<< Previous | Next >>>
